Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC65249 structure
    GC65249STL127705
    CAS: 1326852-06-5
    纯度: >98.00%

    STL127705 (Compound L) 是一种有效的 Ku 70/80 异二聚体蛋白 Ku 70/80 heterodimer protein 抑制剂,IC50 为 3.5 μM。STL127705 通过抑制 DNA-PKCS 激酶的激活干扰 Ku70/80 与 DNA 的结合。STL127705 显示出抗增殖和抗肿瘤活性。 STL127705 诱导细胞凋亡 (apoptosis) 。

  • GC65253 structure
    GC65253PCC0208017
    CAS: 2623158-64-3
    纯度: >99.00%

    PCC0208017 是有效的微管亲和力调节激酶 MARK3/MARK4 抑制剂,IC50 值分别为 1.8 和 2.01 nM。 PCC0208017 对 MARK1 和 MARK2 的抑制活性要低得多,IC50 值分别为 31.4 和 33.7 nM。 PCC0208017 在体内外都抑制神经胶质瘤进展。PCC0208017 破坏微管动力学并诱导 G2/M 期细胞周期停滞和细胞凋亡。PCC0208017 具有强大的抗肿瘤活性并显示出良好的 BBB 通透性。

  • GC65282 structure
    GC65282STING agonist-12
    CAS: 2259624-71-8
    纯度: >98.00%

    A STING agonist

  • GC65283 structure
    GC65283AXC-715 trihydrochloride
    CAS: 2479276-17-8
    纯度: >99.00%

    AXC-715 (T785) trihydrochloride 是一种 TLR7/TLR8 双激动剂,从专利 WO2020168017 A1 中获得。AXC-715 trihydrochloride 可用于合成抗体佐剂免疫偶联物,偶联物包括一个与程序性死亡配体 1 (PD-L1) 连接到一个或多个佐剂的抗体结构上。

  • GC65291 structure
    GC65291IL-15-IN-1
    CAS: 1831830-20-6
    纯度: >99.00%

    IL-15-IN-1是有效,选择性的抑制剂,抑制IL-15依赖性细胞的 IC50 为0.8 μM。

  • GC65293 structure
    GC65293AB-680
    CAS: 2105904-82-1
    纯度: >98.00%

    AB-680 是一种有效、可逆、选择性的 CD73 (胞外核苷酸酶) 抑制剂,对 hCD73 的 Ki 值为 4.9 pM,对其选择性是对相关胞外核苷酸酶 CD39 的 10000 多倍。具有抗肿瘤活性。

  • GC65307 structure
    GC65307S130
    CAS: 1160852-22-1
    纯度: >99.00%

    S130 是一种高亲和力、选择性的半胱氨酸蛋白酶 ATG4B 的抑制剂, IC50 值为 3.24 µM。S130 可以抑制自噬通量。

  • GC65344 structure
    GC65344STAT5-IN-2
    CAS: 2111834-61-6
    纯度: >98.00% / >99.00%

    STAT5-IN-2是一种具有口服活性的STAT5抑制剂。STAT5-IN-2能够有效阻断STAT5的磷酸化和转录活性。

  • GC65365 structure
    GC65365IAXO-102
    CAS: 1115270-63-7
    纯度: >98.00%

    A glycolipid TLR4 antagonist

  • GC65373 structure
    GC65373(R)-IL-17 modulator 4
    CAS: 2446804-29-9
    纯度: >99.00%

    (R)-IL-17 modulator 4 是 IL-17 modulator 4 的 R 构型形式。 IL-17 modulator 4 是一种 IL-17 modulator 1 的前药。IL-IL-17 modulator 1是一种具有口服活性的,高效的 IL-17 调节剂。

  • GC65395 structure
    GC65395T025
    CAS: 2407433-00-3
    纯度: >98.00%

    T025 是口服有效的Cdc2-like 激酶 (CLK) 抑制剂,对 CLK1,CLK2,CLK3,CLK4,DYRK1A,DYRK1B 和 DYRK2 的 Kd 分别为4.8,0.096,6.5,0.61,0.074,1.5 和 32 nM。T025 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。T025 可降低 CLK 依赖性磷酸化。T025 在血液和实体癌细胞系中均具有抗增殖活性 (IC50值:30-300 nM)。T025 具有抗肿瘤功效,主要用于MYC驱动的疾病研究。

  • GC65423 structure
    GC65423Procyanidol B4
    CAS: 29106-51-2
    纯度: >99.00%

    A polyphenol flavonoid dimer with diverse biological activities

  • GC65428 structure
    GC65428BLM-IN-1
    CAS: 2056014-40-3
    纯度: >99.00%

    BLM-IN-1 (compound 29) 是有效的、布鲁姆综合征蛋白 (BLM) 的抑制剂,对BLM的KD 值为1.81 μM,IC50 值为0.95 μM。可诱导DNA损伤反应,癌细胞的凋亡和增殖抑制。

  • GC65429 structure
    GC65429Capillarisin
    CAS: 56365-38-9
    纯度: >98.00%

    Capillarisin 作为蒿属植物蒿的一种成分,具有抗炎和抗氧化作用。Capillarisin 可为哮喘介导并发症的研究,并且可以作为一种潜在的神经保护剂来对抗布比卡因引起的神经毒性。

  • GC65433 structure
    GC65433Tafasitamab
    CAS: 1422527-84-1

    Tafasitamab (XmAb5574) 是一种 Fc 修饰的人源化单克隆抗体,可与人 B 细胞表面抗原 CD19 结合。

  • GC65435 structure
    GC65435Monalizumab
    CAS: 1228763-95-8
    纯度: >99.00%

    Monalizumab 是一种首创的靶向自然杀伤细胞群 2A (NKG2A) 的免疫检查点抑制剂。Monalizumab 是一种人源化抗 NKG2A 的单克隆抗体,可增加 IFN-γ 产生,从而促进自然杀伤细胞功能。Monalizumab 可用于头颈部鳞状细胞癌 (HNSCC) 的研究。

  • GC65442 structure
    GC65442Musk ketone
    CAS: 81-14-1
    纯度: >97.00%

    Musk ketone (MK) 是一种应用广泛的人工香料。Musk ketone 对 Hep G2 细胞具有致突变性和致伤性作用,通过激活 PI3K/Akt 信号通路诱导神经干细胞在脑缺血时增殖分化。 Musk ketone 通过抑制细胞凋亡 (apoptosis) 对脑卒中损伤起到神经保护作用。

  • GC65446 structure
    GC65446α-Amyrin acetate
    CAS: 863-76-3

    α-?Amyrin acetate,一种三萜类化合物,具有抗炎活性、抗痉挛特性和松弛作用。

  • GC65448 structure
    GC65448ODN 1826
    CAS: 202668-42-6
    纯度: >93.00% / >97.00% / >98.00%

    ODN 1826 为 B 类 CpG ODN (寡脱氧核苷酸),是一种 TLR9 激动剂。ODN 1826 是一种在小鼠模型中诱导 NO 和 iNOS 产生的极好的免疫刺激剂。 CpG ODN 1826 增强细胞凋亡( apoptosis)。ODN 1826 序列:5'-tccatgacgttcctgacgtt-3'。

  • GC65460 structure
    GC65460HDACs/mTOR Inhibitor 1
    CAS: 2271413-06-8
    纯度: >98.00%

    HDACs/mTOR Inhibitor 1 是组蛋白去乙酰酶抑制剂 (HDAC) 和哺乳动物雷帕霉素 (mTOR) 的双重抑制剂,有潜力用于恶性血液病的研究,其对 HDAC1、HDAC6、mTOR 和 PI3Kα 的 IC50 值分别为 0.19 nM、1.8 nM、1.2 nM 和 >500 nM。HDACs/mTOR Inhibitor 1 能够引起 G0/G1 期的细胞阻滞,诱导肿瘤细胞凋亡,在体内毒性较低。

  • GC65470 structure
    GC65470Oleclumab
    CAS: 1803176-05-7
    纯度: >98.00%

    Oleclumab (MEDI9447) 是一种人 IgG1Λ 抗 CD73 单克隆抗体,可抑制 CD73 功能。Oleclumab 具有抗肿瘤活性。

  • GC65475 structure
    GC65475Euparin
    CAS: 532-48-9
    纯度: >99.00%

    Euparin 是苯并呋喃的单体化合物,是一种活性氧 (ROS) 抑制剂。 Euparin 对脊髓灰质炎病毒具有抗病毒活性,并且还具有抗抑郁作用。

  • GC65542 structure
    GC65542NSC-87877 disodium
    CAS: 56932-43-5

    A potent inhibitor of SHP- 1 and SHP- 2

  • GC65545 structure
    GC65545Cyclo(L-Phe-L-Pro)
    CAS: 3705-26-8
    纯度: >98.00%

    Cyclo(L-Phe-L-Pro) 可从 Pseudomonas fluorescens 和 Pseudomonas alcaligenes 无细胞培养上清液中分离得到,是一种抗真菌环状二肽。Cyclo(L-Phe-L-Pro)通过干扰视黄酸诱导基因-I (RIG-I) 的激活来抑制 IFN-β 产生。Cyclo(L-Phe-L-Pro) 还具有自由基清除活性,IC50 为 24 µM。